mani
natur
productderiv
lectin
red
algal
lectin
griffithsin
grft
potent
vitro
activ
virus
display
dens
cluster
oligomannos
nlink
glycan
nlg
surfac
envelop
glycoprotein
howev
sinc
oligomannos
nlg
also
found
host
protein
possibl
treatment
antivir
lectin
may
trigger
undesir
side
effect
antivir
lectin
concanavalin
banana
lectin
cyanovirinn
cvn
interact
lectin
yet
undescrib
cellular
moieti
report
induc
undesir
side
effect
includ
secret
inflammatori
cytokin
activ
host
tcell
show
grft
unlik
cvn
bind
surfac
human
epitheli
peripher
blood
mononuclear
cell
pbmc
exclus
oligosaccharidedepend
interact
contrast
sever
antivir
lectin
howev
grft
treatment
induc
minim
chang
secret
inflammatori
cytokin
chemokin
epitheli
cell
human
pbmc
measur
effect
cell
viabil
significantli
upregul
marker
tcell
activ
addit
grft
appear
retain
antivir
activ
bound
surfac
pbmc
final
rna
microarray
studi
show
cvn
cona
regul
express
multitud
cellular
gene
grft
treatment
effect
minim
alter
gene
express
profil
human
ectocerv
cell
line
studi
indic
grft
outstand
safeti
profil
littl
evid
induc
toxic
tcell
activ
deleteri
immunolog
consequ
uniqu
attribut
natur
productderiv
lectin
prototyp
exampl
viru
util
oligomannoserich
glycan
shield
occlud
function
import
domain
envelop
glycoprotein
antibodi
evad
immun
respons
recent
door
et
al
show
previou
measur
proport
oligomannos
nlg
rel
complex
nlg
recombin
hiv
envelop
glycoprotein
underestim
represent
oligomannos
nlg
nativ
envelop
spike
appear
display
nlg
almost
exclus
mannosetermin
man
glcnac
structur
like
limit
access
high
densiti
nlg
present
trimer
glycoprotein
spike
golgi
endoplasm
reticulum
er
mannosidas
result
atyp
preponder
oligomannos
glycan
rather
complex
nlg
surfac
glycoprotein
given
man
glcnac
structur
present
less
normal
human
nglycom
dens
cluster
oligomannos
nlg
appear
featur
specif
viral
envelop
glycoprotein
particularli
immunodefici
lentivirus
consequ
cluster
oligomannos
nlg
may
attract
molecular
target
antivir
drug
vaccin
act
interrupt
infect
target
cell
bind
viru
envelop
therebi
interf
structur
transit
involv
receptor
coreceptor
dock
viru
entri
tcell
ii
block
access
viral
envelop
oligomannos
nlg
target
ctype
lectin
receptor
dcsign
mmr
dendrit
cell
macrophag
long
known
varieti
oligomannosespecif
lectin
potent
vitro
inhibitori
activ
therefor
propos
microbicid
candid
topic
prophylaxi
infect
potenti
therapeut
howev
mani
lectin
possess
lymphocyt
mitogen
activ
incompat
use
pharmaceut
known
human
anim
toxin
although
pharmacolog
basi
toxic
poorli
character
antivir
potenc
lectin
correl
capac
bind
multipl
glycan
simultan
often
facilit
abil
form
dimer
higher
order
multim
extens
character
antivir
lectin
cvn
small
protein
exist
monomer
homodimer
configur
except
potent
antihiv
activ
low
nanomolar
rang
cvn
target
termin
glycan
display
man
glcnac
structur
surfac
mani
viral
envelop
glycoprotein
monom
cvn
capac
bind
two
oligomannos
structur
formul
carboxyethylcellulos
gel
matrix
cvn
provid
almost
complet
protect
singl
high
dose
intrarect
intravagin
challeng
pathogen
simianhuman
immunodefici
viru
shiv
howev
subsequ
vitro
toxic
studi
rais
concern
safeti
cvn
base
microbicid
find
vitro
cvn
capac
promot
secret
proinflammatori
cytokin
chemokin
human
peripher
blood
mononuclear
cell
pbmc
activ
quiescent
tcell
promot
tcell
prolifer
similar
result
also
report
lectin
microvirin
mvn
concanavalin
con
note
toxic
cvn
much
milder
treat
cervic
explant
comparison
pbmc
possibl
pathogen
consequ
associ
offtarget
activ
rais
concern
member
natur
productbas
class
antivir
lectin
grft
potent
broad
spectrum
inhibitori
activ
yet
describ
antivir
lectin
kda
domainswap
homodim
first
amino
acid
kda
monom
complet
bprism
fold
homodim
six
carbohydr
bind
pocket
locat
opposit
end
doublepr
homodim
atom
resolut
crystal
structur
engin
monomer
grft
show
monom
bind
two
differ
nonamannosid
molecul
three
carbohydr
bind
site
antivir
activ
monomer
grft
substanti
lower
homodimer
form
confirm
grft
potenc
depend
abil
bind
multipl
oligomannos
structur
simultan
strong
avid
show
recent
grft
caus
mitogen
stimul
pbmc
expos
drug
grft
fulli
activ
presenc
macaqu
vagin
secret
shown
good
safeti
profil
rabbit
vagin
irrit
model
gold
standard
preclin
safeti
test
vagin
product
moreov
treatment
human
cervic
explant
grft
induc
minim
alter
express
profil
panel
proinflammatori
chemokin
cytokin
grft
also
strongli
inhibit
infect
cervic
explant
dissemin
infect
cell
resid
explant
donor
tcell
present
studi
perform
comprehens
set
experi
interrog
molecular
respons
cultur
human
cervicovagin
cell
pbmc
grft
exposur
investig
employ
comparison
biolog
activ
grft
bind
mannosetermin
man
glcnac
lectin
welldefin
carbohydr
bind
specif
cvn
bind
termin
glycan
man
glcnac
structur
phytohemagglutinin
pha
target
dgalactos
nacetyldgalactosamin
gycan
structur
cona
specif
termin
tri
mannos
high
mannos
glycan
pokewe
agglutinin
pkm
bind
nacetylglucosamin
studi
reveal
clear
distinct
biolog
toxicolog
properti
lectin
confirm
grft
superior
safeti
profil
use
topic
microbicid
grft
cvn
bind
human
cervic
epithelium
cultur
human
cervicovagin
cell
pbmc
use
paraffinembed
cervic
epitheli
section
old
donor
evalu
bind
pattern
fluoresc
label
grft
cvn
human
mucos
epithelia
grft
lec
mutant
form
grft
elimin
lectin
activ
mutat
six
mannos
bind
site
use
control
help
distinguish
bind
mediat
grft
carbohydr
bind
pocket
versu
bind
associ
grft
structur
light
micrograph
figur
show
h
e
stain
cervic
tissu
section
orient
observ
microanatomi
human
cervic
epithelium
differ
layer
squamou
epithelium
start
basement
membran
basal
parabas
intermedi
superfici
evid
cervic
connect
tissu
stroma
beneath
basement
membran
tissu
incub
label
grft
grft
lecand
cvn
shown
fig
c
respect
minim
fluoresc
seen
tissu
expos
grft
lec
fig
compar
grftstain
tissu
fig
confirm
bind
grft
outermost
layer
squamou
epithelium
via
carbohydr
bind
activ
distinct
differ
evid
bind
pattern
grft
fig
rel
cvn
fig
bound
far
extens
grft
throughout
layer
squamou
epithelium
basement
membran
underli
stromal
tissu
addit
fluoresc
micrograph
provid
fig
cultur
cervicovagin
epitheli
cell
also
observ
bind
grft
cvn
grft
lecto
cell
compar
fig
h
well
cell
data
shown
use
flow
cytometri
evalu
bind
fluoresc
label
grft
grft
lecand
cvn
human
pbmc
clear
shift
fluoresc
intens
show
grft
fig
cvn
fig
effici
bind
surfac
human
pbmc
rel
grft
lec
fig
observ
minim
bind
bind
grft
surfac
pbmc
significantli
reduc
occlud
glycan
bind
pocket
preincub
yeast
mannan
fig
interestingli
bind
cvn
pbmc
reduc
elimin
mannan
bind
impli
second
mode
bind
cvn
cell
surfac
fig
assum
distinct
popul
differenti
label
cell
seen
flow
histogram
reflect
differ
amount
label
protein
bind
differ
subpopul
leukocyt
unfraction
pbmc
sampl
freshlyisol
pbmc
preincub
hr
grft
variou
concentr
wash
infect
strain
bal
without
ad
new
compound
grft
inhibit
viral
replic
day
cell
cultur
fig
control
maraviroc
mvr
mm
includ
also
show
antihiv
activ
day
cultur
compound
known
bind
specif
receptor
howev
lower
concentr
maraviroc
mm
retain
antivir
activ
assay
protocol
data
shown
mtt
assay
use
assess
effect
grft
cell
viabil
measur
metabol
activ
treat
cell
experi
fig
observ
loss
cell
viabil
day
exposur
endocerv
ectocerv
cell
line
concentr
mgml
mm
grft
least
concentr
like
microbicid
formul
high
dose
grft
howev
slightli
reduc
viabil
vagin
keratinocyt
cell
mark
contrast
grft
mannosespecif
mitogen
lectin
cona
show
clear
concentrationdepend
cytotox
toward
three
cell
line
shown
fig
treatment
mm
cona
kill
approxim
ectocerv
cell
vagin
keratinocyt
endocerv
cell
pha
anoth
lectin
known
mitogen
vivo
vitro
also
caus
doserespons
cell
death
lesser
extent
cona
previous
show
grft
exhibit
mitogen
stimulatori
effect
human
pbmc
use
incorpor
tritiat
thymidin
marker
cell
prolifer
present
studi
investig
mitogen
activ
grft
pbmc
flow
cytometri
evalu
chang
size
morpholog
cell
treat
grft
comparison
cell
treat
vehicl
pb
cell
treat
mm
grft
flow
cytometri
profil
similar
control
cell
fig
b
c
contrast
treatment
lectin
cona
pha
dose
mm
cona
mgml
pha
neg
affect
cell
viabil
result
complet
differ
flow
cytometr
plot
emerg
subpopul
compos
larger
cell
higher
forward
scatter
fsc
percept
higher
side
scatter
ssc
valu
gate
region
shown
fig
e
addit
clear
decreas
cell
number
observ
region
treatment
cona
pha
quantifi
fig
fig
show
grft
also
induc
cell
prolifer
three
cultur
human
cervic
vagin
epitheli
cell
cell
divis
assess
monitor
brdu
incorpor
newli
synthes
dna
activ
divid
cervicovagin
cell
line
treatment
mm
grft
induc
prolifer
cell
line
sinc
brdu
count
elev
comparison
control
cell
treat
vehicl
alon
pb
contrast
pokewe
agglutinin
pkm
well
character
mitogen
caus
concentrationdepend
increas
cell
divis
especi
cervic
cell
line
evalu
effect
grft
cell
surfac
marker
immun
activ
measur
express
follow
membran
protein
marker
activ
tlymphocyt
consid
earli
marker
tcell
activ
ii
alpha
chain
receptor
upregul
activ
tcell
highli
suscept
infect
henc
induct
marker
indic
undesir
side
effect
lectin
treatment
pbmc
pbmc
incub
presenc
test
compound
hour
vehicl
control
pb
posit
control
mgml
pha
well
mm
cona
chosen
concentr
cytotox
pb
treat
cell
pbmc
averag
doubl
posit
non
signific
increas
popul
observ
incub
presenc
mm
grft
fig
left
panel
fig
treatment
pha
cona
result
impress
increas
number
cell
fig
left
panel
fig
addit
number
cell
elev
pbmc
cultur
presenc
pha
cona
compar
pb
grft
counterpart
fig
left
panel
data
shown
similarli
grft
treatment
affect
significantli
proport
pbmc
compar
pb
treatment
wherea
cona
pha
treatment
result
increas
time
subpopul
fig
middl
panel
fig
number
also
elev
treatment
cona
pha
fig
middl
panel
data
shown
unstimul
cell
posit
pbmc
express
late
activ
marker
hladr
treatment
grft
cona
affect
number
signific
fashion
fig
right
panel
fig
pha
treatment
cell
yield
twice
number
hladr
cell
compar
unstimul
pbmc
activ
pbmc
may
also
reflect
product
cytokin
chemokin
investig
potenti
activ
properti
grft
thoroughli
pbmc
cultur
presenc
mgml
grft
nm
h
cultur
supernat
concentr
eotaxin
fgf
gcsf
gmcsf
ifnc
pdgfbb
rant
tnfa
vegf
determin
detail
overview
cytokin
profil
grfttreat
pbmc
multipl
blood
donor
given
fig
refer
provid
previous
publish
data
pbmc
donor
origin
treat
cvn
mgml
nm
lower
grft
concentr
test
sinc
higher
concentr
cvn
prove
toxic
pbmc
concentr
separ
cytokin
compar
untreat
pbmc
calcul
fold
increas
valu
previou
studi
pbmc
treatment
cvn
mvn
consider
variabl
lectininduc
cytokin
profil
observ
differ
pbmc
donor
therefor
fold
increas
valu
obtain
differ
donor
divid
differ
rank
group
ie
increas
number
rank
given
percentag
total
indic
specif
color
fig
confirm
data
fig
grft
littl
effect
lymphocyt
activ
marker
also
see
minim
alter
cytokin
chemokin
releas
major
marker
donor
pbmc
profil
indic
grft
induc
significantli
less
respons
pbmc
previous
report
cvn
mvn
cona
chemokin
induc
weakli
grft
major
donor
although
studi
perform
later
date
previous
publish
cvn
mvn
studi
use
exactli
donor
panel
assay
perform
laboratori
schol
justifi
comparison
experi
previous
publish
studi
show
treatment
human
cervic
explant
rang
grft
concentr
signific
effect
express
panel
chemokin
cytokin
present
studi
use
cultur
human
endocerv
ectocerv
vagin
cell
line
detail
analysi
potenti
offtarget
effect
grft
treatment
sinc
cell
line
easier
procur
fresh
human
cervic
tissu
experi
cell
line
easili
reproduc
without
question
variabl
genet
background
physiolog
condit
donor
valid
util
cell
line
immort
induct
papillomaviru
oncogen
analysi
offtarget
effect
grft
treatment
wish
confirm
cell
line
behav
similarli
cervic
explant
treatment
grft
cona
induc
inflammatori
respons
pbmc
studi
assess
secret
mani
key
mediat
inflammatori
respons
includ
three
cervicovagin
cell
line
elisa
kit
specif
cytokin
use
detect
cell
cultur
supernat
h
incub
presenc
test
compound
treatment
mm
grft
supernat
show
bare
detect
level
similar
cell
treat
pb
fig
b
contrast
three
cell
line
produc
impress
amount
cytokin
upon
incub
presenc
cona
fig
b
treatment
cervic
epitheli
cell
line
grft
mm
cona
mm
pb
result
similar
level
secret
fig
releas
approxim
three
time
higher
cona
treatment
compar
pb
wherea
grft
induc
secret
cytokin
fig
case
three
cell
line
show
distinct
pattern
secret
cytokin
although
induct
observ
treatment
mm
grft
show
bare
detect
level
regardless
treatment
level
rel
high
pb
grft
treatment
amount
ten
time
reduc
treatment
cona
grft
treatment
result
slight
decreas
cell
cultur
supernat
wherea
concentr
cytokin
significantli
increas
follow
treatment
cona
fig
addit
grft
treatment
alter
product
tgfa
cervicovagin
cell
studi
data
shown
data
indic
cell
line
behav
predict
respons
grft
cona
treatment
sinc
ectocerv
epithelium
import
point
mucos
transmiss
focus
cell
line
deriv
comprehens
assess
effect
grft
treatment
cytokin
product
cultur
ectocerv
cell
multiplex
luminex
assay
cell
line
treat
grft
confirm
cell
behav
similarli
human
cervic
explant
data
shown
valid
use
cell
microarray
studi
gene
express
cell
respons
treatment
grft
compar
vehicl
pb
grft
lec
cvn
cona
treatment
qualifi
endotoxin
level
less
eu
per
milligram
studi
use
microarray
experi
whole
human
genom
repres
known
gene
transcript
microarray
data
deposit
gene
express
omnibu
databas
access
number
heat
map
shown
fig
indic
cell
expos
hour
grft
lec
mm
low
concentr
grft
mm
cvn
mm
show
compar
gene
express
profil
incub
presenc
pb
alon
treatment
mm
grft
result
minor
chang
express
profil
mm
grft
appear
alter
express
mani
gene
much
lesser
extent
compar
cvn
mm
cona
mm
fig
thu
microarray
studi
confirm
data
show
grft
substanti
lower
offtarget
effect
comparison
cvn
cona
although
clearli
sever
gene
regul
carbohydr
bind
activ
grft
compar
grft
lec
predict
heat
map
fig
gene
identifi
regul
mm
grft
even
cutoff
brought
howev
first
analysi
use
benjaminihochberg
low
stringenc
correct
cutoff
yield
entri
differenti
express
sampl
treat
mm
grft
respect
fig
treatment
cvn
mm
cona
mm
result
regul
impress
number
human
gene
fig
employ
stricter
criteria
keep
posit
entri
show
grft
concentr
depend
gene
express
yield
gene
mm
grft
respect
entri
show
increas
gene
express
treatment
mm
grft
includ
gene
annot
immunoglobulinlik
fibronectin
type
iii
domain
contain
entri
found
affect
mm
grft
summar
tabl
among
gene
map
ingenu
databas
overrepresent
gene
follow
canon
pathway
oxid
stress
respons
maf
phospholipid
degrad
glycerophospholipid
metabol
signal
camp
mediat
signal
pkib
acut
phase
respons
signal
furthermor
use
ingenu
softwar
identifi
five
toxicolog
function
overrepresent
gene
includ
liver
hyperbilirubinemia
steatohepat
cardiac
arteriopathi
renal
liver
necrosi
data
shown
none
relev
mucos
treatment
grft
use
quantit
rtpcr
qrtpcr
valid
microarray
result
express
gene
studi
use
rna
bactin
mrna
control
except
mycn
gene
studi
show
compar
express
level
experiment
system
includ
microarray
qpcr
tabl
natur
product
lectin
receiv
consider
attent
potenti
antivir
drug
particularli
context
prevent
transmiss
via
mucos
surfac
review
recent
although
volum
literatur
support
use
antivir
vivo
dwarf
comprehens
set
data
show
potent
vitro
antivir
activ
report
impress
vivo
efficaci
cvn
anim
model
prevent
influenza
prevent
treatment
ebola
viru
prophylaxi
treatment
grft
prevent
sarscov
infect
despit
myriad
potenti
prophylact
therapeut
applic
antivir
lectin
enthusiasm
develop
pharmaceut
temper
long
histori
research
natur
product
lectin
character
mani
member
broad
class
erythrocyt
agglutinin
lymphocyt
mitogen
potenti
lethal
toxin
pharmacolog
basi
natur
product
lectin
toxic
gener
poorli
understood
basic
mechanist
level
thought
resid
lectin
capac
multival
bind
cell
surfac
glycan
result
cell
agglutin
crosslink
cell
surfac
receptor
molecul
consequ
activ
signal
pathway
differ
lectin
bind
ident
glycan
moieti
quit
distinct
biolog
effect
vitro
remain
paradox
well
illustr
data
show
differ
vitro
activ
profil
four
differ
oligomannosebind
lectin
grft
cvn
mvn
cona
character
grft
primari
focu
studi
understand
molecular
pharmacolog
toxicolog
potent
antivir
lectin
inform
comparison
cvn
rich
set
vitro
vivo
data
avail
molecul
compar
neutral
activ
mean
ic
valu
clade
c
virus
nm
grft
cvn
protein
bind
oligomannos
glycan
grft
target
termin
mannos
residu
found
man
glcnac
cvn
specif
linkag
found
man
glcnac
thu
share
overlap
bind
specif
target
ident
cell
surfac
viral
glycan
anyth
grft
would
predict
bind
larger
number
glycan
target
cvn
sinc
bind
pentamannos
structur
lack
mannos
linkag
cvn
target
context
surpris
cvn
appear
bind
promiscu
grft
throughout
cervic
epithelium
subepitheli
stroma
fig
fig
given
grft
lec
carbohydratebind
defici
form
grft
hardli
bound
epitheli
section
cultur
cervic
vagin
epitheli
cell
fig
grft
bind
cultur
epitheli
cell
block
mannan
conclud
grft
bind
activ
cell
surfac
exclus
via
carbohydr
bind
activ
interest
note
cvn
bind
surfac
pbmc
entir
elimin
block
carbohydr
bind
site
mannan
fig
impli
capac
bind
induc
signal
cell
may
resid
entir
lectin
activ
support
prior
studi
cvn
anoth
import
result
show
grft
seem
bind
somewhat
select
termin
differenti
keratinocyt
epitheli
surfac
presum
reflect
presenc
optim
glycoprotein
bind
target
surfac
cell
intact
epithelium
fig
fig
data
present
fig
strongli
support
grft
candidaci
microbicid
antivir
sinc
show
grft
retain
antivir
activ
even
complex
surfac
pbmc
contrast
mani
lectin
compound
test
assay
plausibl
mechan
might
explain
grft
retent
entri
inhibit
activ
fewer
six
carbohydr
bind
site
occupi
lectin
dock
cell
surfac
glycoprotein
leav
site
avail
bind
viral
envelop
glycoprotein
crystal
structur
grft
suggest
three
glycanbind
pocket
grft
monom
opposit
end
doubl
prism
homodim
suggest
one
monom
homodim
engag
bind
cell
surfac
leav
free
monom
compet
bind
crosslink
two
oligomannos
structur
surfac
sinc
pbmc
wash
extens
hour
treatment
prior
addit
inoculum
suggest
cell
surfacebound
grft
irrevers
inactiv
inoculum
evid
breakthrough
infect
day
post
infect
durat
antivir
activ
unpreced
convent
antivir
potenc
virustarget
entri
inhibitor
drug
measur
without
wash
cell
prior
addit
virus
tradit
antivir
assay
ic
grft
bal
nm
pbmc
nm
bal
monocytesmacrophag
data
shown
remark
ic
grft
wash
pbmc
assay
fig
test
agent
appli
hour
prior
cell
wash
infect
nm
show
quit
except
antivir
activ
grft
assay
show
activ
antagonist
maraviroc
persist
hr
although
high
concentr
grft
activ
persist
substanti
longer
properti
may
facilit
noncoit
link
administr
microbicid
contain
grft
activ
ingredi
cardin
rule
develop
microbicid
must
first
harm
random
control
preclin
clinic
studi
detergentbas
microbicid
show
trend
toward
evid
harm
increas
incid
infect
also
hpv
seen
experiment
arm
microbicid
field
therefor
requir
stringent
extens
vitro
vivo
safeti
studi
human
trial
initi
initi
studi
show
grft
cytotox
mitogen
activ
induc
secret
chemokin
cytokinemedi
inflamm
treat
cervic
explant
show
good
safeti
profil
rabbit
vagin
irrit
test
first
tissu
grft
would
expos
human
vagina
keratinocyt
outer
surfac
vagin
cervic
epithelia
grft
would
also
encount
target
cell
dendrit
cell
macrophag
resid
epithelium
submucos
stroma
well
primari
target
cell
mucos
tcell
work
expand
safeti
studi
includ
analys
offtarget
effect
deriv
grft
bind
cell
surfac
oligomannos
glycan
human
pbmc
well
character
ectocerv
endocerv
vagin
keratinocyt
cell
line
origin
establish
normal
human
endocerv
ectocerv
vagin
epithelia
respect
immort
express
human
papillomaviru
immort
cell
line
shown
close
resembl
respect
tissu
origin
primari
cultur
morpholog
immunocytochem
characterist
therefor
propos
studi
deal
test
pharmacolog
agent
intravagin
applic
first
evalu
effect
grft
cell
viabil
show
mm
grft
decreas
cell
viabil
cervic
cell
line
wherea
somewhat
sensit
grft
high
concentr
mm
result
consist
pioneer
work
mori
cowork
signific
cellular
toxic
found
varieti
human
cell
type
treat
grft
concentr
mm
sinc
mani
lectin
report
mitogen
examin
grft
would
effect
cervicovagin
cell
prolifer
use
colorimetr
assay
detect
brdu
newli
synthes
dna
show
high
concentr
grft
increas
prolifer
either
evalu
concentr
panel
cytokin
chemokin
cervicovagin
cell
cultur
supernat
use
elisa
found
high
concentr
grft
littl
effect
secret
cytokineschemokin
studi
includ
tgfa
three
cervicovagin
cell
line
includ
therefor
result
taken
togeth
suggest
grft
concentr
alter
secret
immun
system
mediat
cervicovagin
cell
signific
fashion
use
cell
model
test
grft
order
evalu
effect
gene
express
night
incub
knowledg
first
studi
evalu
effect
antihiv
lectin
gene
express
use
human
genom
microarray
data
reveal
exposur
grft
mm
affect
gene
express
wherea
treatment
mm
grft
result
minor
alter
gene
express
profil
show
gene
consid
significantli
upregul
cutoff
note
work
concentr
high
instanc
mm
correspond
time
time
ec
found
resist
sensit
strain
respect
higher
concentr
mm
grft
gene
consid
differenti
express
cutoff
fold
chang
found
less
equal
qrtpcr
evalu
express
select
gene
valid
microarray
data
present
unclear
biolog
relev
signific
level
regul
use
cell
line
sharkey
et
al
classifi
gene
differenti
express
fold
chang
found
total
probe
set
fell
categori
treat
cell
h
human
semin
plasma
sharp
contrast
treatment
mm
grft
level
least
fold
greater
averag
antivir
ec
regul
express
gene
summari
data
provid
evid
grft
except
potent
antivir
lectin
minor
effect
molecular
physiolog
human
cell
point
molecular
basi
distinct
biolog
activ
differ
antivir
lectin
uncharacter
propos
specif
spatial
arrang
carbohydr
bind
site
may
determin
natur
extent
crosslink
cell
surfac
glycoprotein
grft
clearli
superior
bind
crosslink
activ
envelop
glycoprotein
display
dens
cluster
oligomannos
nlg
induc
offtarget
cellular
signal
extent
lectin
believ
provid
data
strong
support
focus
clinic
develop
microbicid
contain
grft
activ
ingredi
recombin
grft
produc
nicotiana
benthamiana
plant
recombin
cvn
produc
escherichia
coli
method
express
purif
product
describ
previous
synthet
cdna
encod
lectin
activitydefici
mutant
grft
term
grft
lec
design
conserv
amino
acid
substitut
aspart
acid
asparagin
carbohydr
bind
pocket
identifi
primari
amino
acid
sequenc
crystal
structur
grft
grft
lecwa
express
n
benthamiana
purifi
exactli
describ
grft
protein
purifi
puriti
formul
phosphat
buffer
salin
pb
ph
mgml
protein
concentr
endotoxin
remov
grft
grft
lecand
cvn
protein
sampl
use
detoxigel
endotoxinremov
gel
graviti
flow
column
thermo
scientif
endotoxin
level
measur
use
toxinsensor
tm
chromogen
lal
endotoxin
assay
kit
genscript
piscataway
nj
product
final
endotoxin
read
less
endotoxin
unit
eu
per
milligram
use
vitro
studi
dilut
perform
endotoxinfre
buffer
grft
grft
lecand
cvn
fluorescentlylabel
aminereact
alexa
fluor
carboxyl
acid
succinimidyl
ester
use
kit
molecular
probesinvitrogen
accord
manufactur
specif
control
lectin
concanavalin
cona
phytohemagglutinin
pha
pokewe
agglutinin
pkm
purchas
sigma
lectin
activ
measur
use
elisa
immobil
protein
scienc
corpor
use
measur
lectin
activ
purifi
grft
cvn
fluoresc
label
conjug
thereof
confirm
grft
leclack
bind
activ
nunc
maxisorp
elisa
plate
coat
overnight
mgml
strain
iiib
protein
scienc
dilut
pb
well
block
wv
nonfat
dri
milk
tween
pbst
immunowash
biorad
wash
addit
serial
dilut
lectin
analyt
grft
grft
lec
cvn
alexafluor
conjug
thereof
dilut
pb
h
three
wash
pbst
primari
polyclon
antiserum
rabbit
antigrft
cvn
alexafluor
invitrogen
appropri
dilut
pb
ad
h
room
temperatur
well
wash
goat
antirabbit
igghrp
southern
biotech
ad
dilut
colorimetr
valu
reflect
hrp
activ
deriv
use
kpl
sureblu
tmb
microwel
peroxidas
substrat
reaction
stop
addit
n
h
plate
read
nm
biotek
synergi
ht
reader
data
collect
use
gemini
softwar
confirm
label
product
retain
lectin
activ
compar
unlabel
product
elisa
use
elisa
antialexafluor
detect
measur
total
amount
label
conjug
grft
grft
lecand
cvn
display
quantit
similar
label
effici
well
character
immort
cell
line
deriv
normal
human
endocerv
ectocerv
vagin
epithelia
respect
cell
line
purchas
american
type
cultur
collect
atcc
rockvil
md
cervicovagin
cell
line
grown
previous
describ
keratinocyt
serumfre
medium
ksfm
supplement
recombin
human
epiderm
growth
factor
ngml
bovin
pituitari
extract
mgml
calcium
chlorid
mm
antibiot
cocktail
compos
penicillin
streptomycin
final
concentr
uml
mgml
respect
reagent
obtain
invitrogen
sandiego
ca
sigma
chemic
compani
cryopreserv
human
pbmc
use
assay
inflammatori
cytokin
chemokin
purchas
seracar
life
scienc
inc
milford
immedi
cultur
experi
rpmi
supplement
fetal
bovin
serum
fb
penicillinstreptomycin
antibiot
cocktail
uml
mgml
final
concentr
respect
slide
paraffin
embed
human
cervic
tissu
section
healthi
year
old
femal
us
biomax
inc
deparaffin
rehydr
alexafluor
protein
interest
ad
slide
incub
overnight
humid
chamber
slide
rins
pb
twice
minut
coverslip
use
vectashield
mount
media
dapi
vector
laboratori
burlingam
ca
light
microscopi
tissu
section
stain
hematoxylin
eosin
standard
method
cultur
cell
seed
onto
eightwel
labtek
chamber
slide
nalgen
nunc
duplic
cell
per
well
allow
incub
co
eight
hour
fluoresc
label
protein
interest
ad
well
incub
overnight
co
slide
wash
twice
minut
pb
coverslip
use
vectashield
mount
media
dapi
vector
laboratori
burlingam
ca
slide
visual
use
axio
observ
microscop
apotom
assembl
carl
zeiss
thornwood
ny
human
pbmc
seracar
life
scienc
md
thaw
seed
onto
cultur
plate
celltreat
cell
per
well
three
dilut
alexafluor
protein
ad
cell
overnight
incub
co
sampl
also
prepar
mg
mannan
sigma
st
loui
mo
protein
dilut
sampl
analyz
duplic
follow
incub
cell
briefli
trypsin
trypl
express
gibco
place
ml
polystyren
tube
bd
falcon
cell
wash
twice
pb
analyz
use
bd
facsaria
bd
bioscienc
nj
flow
cytomet
freshli
isol
pbmc
cultur
presenc
grft
cvn
maraviroc
hr
cell
collect
wash
cultur
medium
suspend
rpmi
medium
ngml
seed
flat
bottom
plate
cell
ml
ml
clade
b
bal
stock
ad
tcid
supernat
sampl
collect
day
viral
replic
measur
specif
ag
elisa
perkin
elmer
zaventem
belgium
viabil
cervicovagin
cell
line
measur
use
colorimetr
mtt
bromid
assay
kit
biotium
inc
hayward
ca
follow
manufactur
instruct
briefli
cell
per
well
seed
well
plate
test
reagent
ad
cultur
incub
three
day
humid
environ
co
afterward
ml
mtt
solut
ad
well
follow
hour
incub
medium
gentli
remov
insolubl
purpl
formazan
product
dissolv
dmso
yield
color
solut
absorb
read
nm
background
nm
prolifer
cervicovagin
cell
line
evalu
bromodeoxyuridin
brdu
thymidin
analog
incorpor
newli
synthes
dna
use
cell
prolifer
elisa
kit
roch
accord
manufactur
instruct
human
pbmc
cell
treat
grft
three
day
analyz
flow
cytometri
chang
size
andor
morpholog
use
forward
scatter
fsc
side
scatter
ssc
facscalibur
bd
san
jose
ca
count
event
per
sampl
data
acquir
analyz
use
cellquest
pro
bd
cona
mm
pha
mgml
pb
use
control
three
day
old
pbmc
analyz
flowcytometr
dual
fluoresc
stain
antimous
antibodi
purchas
bd
pharmingen
san
diego
ca
briefli
cell
cultur
transfer
plate
ml
round
bottom
tube
wash
pb
contain
inactiv
fb
wash
solut
min
block
purifi
rat
antimous
mous
bd
fc
block
cell
incub
dark
fitcconjug
mab
combin
peconjug
anti
hladr
mab
min
ice
final
pbmc
wash
analyz
facscalibur
bd
san
jose
ca
count
event
per
sampl
data
acquir
analyz
use
cellquest
pro
bd
cona
mm
pha
mgml
pb
use
posit
neg
control
respect
multiplex
immunoassay
carri
bioplex
instrument
biorad
use
milliplex
human
cytokinechemokin
luminex
beadbas
assay
millipor
follow
manufactur
instruct
luminex
immunoassay
repeat
three
time
kit
allow
simultan
quantif
humanepiderm
growth
factor
egf
eotaxin
fibroblast
growth
fmslike
tyrosinekinas
ligand
ligand
fractalkin
granulocyt
colonystimul
factor
gcsf
granulocytemacrophagecsf
gmcsf
gro
ifnc
receptor
antagonist
interferoninduc
monocyt
chemoattract
macrophagederiv
chemokin
mdc
macrophag
inflammatori
mipa
plateletderiv
growth
factoraa
pdgfaa
pdgfabbb
regul
upon
activ
normal
tcell
express
secret
rant
solubl
ligand
solubl
transform
growth
factor
tgfa
tumor
necrosi
factora
tnfa
tnfb
vascular
endotheli
growth
factor
vegf
supernat
collect
hour
cultur
presenc
test
compound
studi
multipleximmuno
assay
data
analyz
use
luminex
r
softwar
individu
elisa
experi
perform
cell
cultur
supernat
collect
hour
incub
presenc
grft
control
elisa
readysetgo
kit
design
accur
precis
measur
human
purchas
ebiosci
inc
quantikineh
elisa
kit
r
system
inc
use
detect
tgfa
quantifi
use
elisa
kit
cellscienc
elisa
perform
accord
manufactur
specif
bioplex
cytokin
assay
human
pbmc
supernat
pbmc
multipl
blood
donor
cultur
h
presenc
mgml
grft
nm
cultur
supernat
concentr
il
gene
express
analysi
cell
cultur
cell
incub
dilut
grft
grft
lec
cvn
cona
vehicl
pb
ph
hour
cell
lyse
use
qiagen
qiashredd
total
rna
extract
use
qiagen
rneasi
mini
kit
total
rna
quantifi
spectrophotometr
sampl
qualiti
check
agil
bioanalyz
agil
technolog
wilmington
de
ng
rna
use
gener
cyanin
crna
aid
low
rna
input
linear
amplif
kit
onecolor
agil
technolog
wilmington
de
accord
manufactur
instruct
ug
label
crna
sampl
fragment
min
use
agil
gene
express
hybrid
kit
agil
technolog
wilmington
de
follow
hybrid
whole
human
genom
agil
oligonucleotid
slide
contain
four
highdefinit
k
microarray
agil
technolog
wilmington
de
hour
hybrid
slide
wash
agil
gene
express
wash
buffer
agil
technolog
wilmington
de
scan
use
agil
microarray
scanner
system
agil
technolog
wilmington
de
onecolor
microarray
imag
extract
featur
extract
softwar
v
agil
technolog
wilmington
de
raw
data
import
genespr
gx
softwar
agil
technolog
wilmington
de
normal
analysi
yield
list
differenti
express
gene
benjammini
hocheberg
correct
control
fals
discoveri
rate
fdr
use
consid
fold
chang
least
compar
pb
treat
sampl
repres
meaning
alter
gene
express
raw
microarray
data
upload
gene
express
ominbu
geo
databas
miamecompli
databas
detail
mged
societi
websit
http
wwwmgedorgworkgroupsmiamehtml
geo
access
number
analysi
regul
gene
carri
use
ingenu
knowledg
databas
ingenu
system
inc
redwood
citi
ca
yield
put
toxicolog
function
canon
pathway
quantit
rtpcr
carri
order
valid
microarray
result
first
strand
cdna
revers
transcrib
ng
rna
employ
high
capac
rnatocdna
kit
appli
biosystem
follow
manufactur
instruct
optim
amount
templat
cdna
ad
reaction
mixtur
contain
ml
gene
express
master
mix
appli
biosystem
water
ml
mixtur
use
set
pcr
reaction
taqmanh
array
standard
well
plate
appli
biosystem
plate
contain
prespot
individu
taqmanh
gene
express
assay
detect
human
cysteineaspart
acid
proteas
beta
defensin
immunoglobulinlik
fibronectin
type
iii
domain
contain
vmyc
myelocytomatosi
viral
relat
oncogen
mycn
thyroglobulin
tg
tgfa
tripartit
motifcontain
well
hous
keep
gene
beta
actin
actb
individu
probe
use
experi
describ
tabl
pcr
amplif
perform
fast
realtim
pcr
system
appliedbiosystem
follow
initi
activ
step
min
cycl
min
min
sd
rq
manag
softwar
appli
biosystem
use
evalu
cycl
threshold
ct
reaction
cycl
number
maxim
amplicon
synthesi
achiev
ratio
deriv
propos
elsewher
group
mean
standard
deviat
deriv
valu
obtain
three
individu
replic
statist
signific
analyz
oneway
analysi
varianc
anova
student
ttest
unless
otherwis
state
use
graphpad
softwar
san
diego
ca
differ
consid
statist
signific
microarray
data
statist
analysi
carri
describ
gene
express
analysi
method
figur
analysi
bind
specif
grft
comparison
grft
lecand
cvn
first
column
depict
ident
fluoresc
micrograph
fig
